Terms: = Ovarian cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4
80 results:
1. Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance.
Dos Santos MV; Holth A; Bischof K; Davidson B
Clin Exp Metastasis; 2024 Feb; 41(1):69-76. PubMed ID: 38141113
[TBL] [Abstract] [Full Text] [Related]
2. Hospital Volume and Quality of Care for Emergency Gynecologic Care.
Kalinowska V; Huang Y; Buckley A; St Clair CM; Pua T; Khoury-Collado F; Hou JY; Hershman DL; Wright JD
Obstet Gynecol; 2024 Feb; 143(2):303-311. PubMed ID: 38086058
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of American College of Radiology ovarian-Adnexal Reporting and Data System ultrasound to predict malignancy risk in adnexal lesions.
Li Y; Shao G; Wu M; Zhang F; Zhang Y; Shao C
J Obstet Gynaecol Res; 2024 Feb; 50(2):225-232. PubMed ID: 37990446
[TBL] [Abstract] [Full Text] [Related]
4. A cross-sectional study on Chinese oncology nurses' knowledge of bone health among cancer patients.
Shan J; Lv S; Chen L; Li T; Li J; Wang S; Zhang C
Support Care Cancer; 2023 Aug; 31(8):501. PubMed ID: 37526757
[TBL] [Abstract] [Full Text] [Related]
5. Germline Genetic Testing After cancer Diagnosis.
Kurian AW; Abrahamse P; Furgal A; Ward KC; Hamilton AS; Hodan R; Tocco R; Liu L; Berek JS; Hoang L; Yussuf A; Susswein L; Esplin ED; Slavin TP; Gomez SL; Hofer TP; Katz SJ
JAMA; 2023 Jul; 330(1):43-51. PubMed ID: 37276540
[TBL] [Abstract] [Full Text] [Related]
6. IFNγ induces bcl3 expression by JAK1/STAT1/p65 signaling, resulting in increased IL-8 expression in ovarian cancer cells.
Gaire B; Padmanabhan S; Zou Y; Uddin MM; Reddy SU; Vancurova I
FEBS Open Bio; 2023 Aug; 13(8):1495-1506. PubMed ID: 37151134
[TBL] [Abstract] [Full Text] [Related]
7. Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1).
Jeong SY; Lee KJ; Cha J; Park SY; Kim HS; Kim JH; Lee JJ; Kim N; Park ST
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557069
[TBL] [Abstract] [Full Text] [Related]
8. Reproductive Outcomes in Young Breast cancer Survivors Treated (15-39) in Ontario, Canada.
Rushton M; Pudwell J; Wei X; Powell M; Richardson H; Velez MP
Curr Oncol; 2022 Nov; 29(11):8591-8599. PubMed ID: 36421330
[TBL] [Abstract] [Full Text] [Related]
9. Polymorphisms rs2010963 and rs833061 of the VEGF gene in polycystic ovary syndrome.
Vicente ALSA; Marqui ABT; Gomes MKO; Assunção-Luiz AV; Balarin MAS; Tanaka SCSV; Resende EAMR; Lima MFP; Cintra MTR
Rev Assoc Med Bras (1992); 2022; 68(6):785-791. PubMed ID: 35766692
[TBL] [Abstract] [Full Text] [Related]
10. Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland.
Pallonen TA; Lempiäinen SMM; Joutsiniemi TK; Aaltonen RI; Pohjola PE; Kankuri-Tammilehto MK
Sci Rep; 2022 Apr; 12(1):6704. PubMed ID: 35469032
[TBL] [Abstract] [Full Text] [Related]
11. Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study.
Gao Y; Zeng S; Xu X; Li H; Yao S; Song K; Li X; Chen L; Tang J; Xing H; Yu Z; Zhang Q; Zeng S; Yi C; Xie H; Xiong X; Cai G; Wang Z; Wu Y; Chi J; Jiao X; Qin Y; Mao X; Chen Y; Jin X; Mo Q; Chen P; Huang Y; Shi Y; Wang J; Zhou Y; Ding S; Zhu S; Liu X; Dong X; Cheng L; Zhu L; Cheng H; Cha L; Hao Y; Jin C; Zhang L; Zhou P; Sun M; Xu Q; Chen K; Gao Z; Zhang X; Ma Y; Liu Y; Xiao L; Xu L; Peng L; Hao Z; Yang M; Wang Y; Ou H; Jia Y; Tian L; Zhang W; Jin P; Tian X; Huang L; Wang Z; Liu J; Fang T; Yan D; Cao H; Ma J; Li X; Zheng X; Lou H; Song C; Li R; Wang S; Li W; Zheng X; Chen J; Li G; Chen R; Xu C; Yu R; Wang J; Xu S; Kong B; Xie X; Ma D; Gao Q
Lancet Digit Health; 2022 Mar; 4(3):e179-e187. PubMed ID: 35216752
[TBL] [Abstract] [Full Text] [Related]
12. Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity.
Cai R; Zhang X; Wang H; Cui T; Halmos G; Sha W; He J; Popovics P; Vidaurre I; Zhang C; Mirsaeidi M; Schally AV
Peptides; 2022 Apr; 150():170716. PubMed ID: 34952135
[TBL] [Abstract] [Full Text] [Related]
13. PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.
Baldelli E; Hodge KA; Bellezza G; Shah NJ; Gambara G; Sidoni A; Mandarano M; Ruhunusiri C; Dunetz B; Abu-Khalaf M; Wulfkuhle J; Gallagher RI; Liotta L; de Bono J; Mehra N; Riisnaes R; Ravaggi A; Odicino F; Sereni MI; Blackburn M; Zupa A; Improta G; Demsko P; Crino' L; Ludovini V; Giaccone G; Petricoin EF; Pierobon M
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34620701
[TBL] [Abstract] [Full Text] [Related]
14. Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancer.
Leung JH; Lang HC; Wang SY; Lo HF; Chan AL
Expert Rev Pharmacoecon Outcomes Res; 2022 Apr; 22(3):489-496. PubMed ID: 34241562
[TBL] [Abstract] [Full Text] [Related]
15. The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker.
Klotz DM; Link T; Goeckenjan M; Wimberger P; Kuhlmann JD
Mol Oncol; 2021 Sep; 15(9):2491-2503. PubMed ID: 33690968
[TBL] [Abstract] [Full Text] [Related]
16. Germline variation of Ribonuclease H2 genes in ovarian cancer patients.
Polaczek R; Schürmann P; Speith LM; Geffers R; Dürst M; Hillemanns P; Park-Simon TW; Liebrich C; Dörk T
J Ovarian Res; 2020 Dec; 13(1):146. PubMed ID: 33353557
[TBL] [Abstract] [Full Text] [Related]
17. cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers.
Fonnes T; Telle IO; Forsse D; Falck R; Trovik J; Haldorsen IS; Krakstad C
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():25-31. PubMed ID: 33161211
[TBL] [Abstract] [Full Text] [Related]
18. Risks of Second Primary Gynecologic cancers following ovarian cancer Treatment in Asian Ethnic Subgroups in the United States, 2000-2016.
Mukand NH; Zolekar A; Ko NY; Calip GS
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2220-2229. PubMed ID: 32856609
[TBL] [Abstract] [Full Text] [Related]
19. Interval debulking surgery is not worth the wait: a National cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy.
Lyons YA; Reyes HD; McDonald ME; Newtson A; Devor E; Bender DP; Goodheart MJ; Gonzalez Bosquet J
Int J Gynecol Cancer; 2020 Jun; 30(6):845-852. PubMed ID: 32341114
[TBL] [Abstract] [Full Text] [Related]
20. Immunoblotting Analysis of Intracellular PD-L1 Levels in Interferon-γ-Treated ovarian cancer Cells Stably Transfected with bcl3 shRNA.
Padmanabhan S; Zou Y; Vancurova I
Methods Mol Biol; 2020; 2108():211-220. PubMed ID: 31939183
[TBL] [Abstract] [Full Text] [Related]
[Next]
